CDK4 and neoplasm: Thus, mitogenic signals suppress ERVs expression via DNA methylation, mediated by the CDK4/6-Cyclin D-Rb-DNMT1 axis, and inhibition of this axis results in ERVs activation followed by enhanced anti-tumor immunity.